ShridarGanesanMDPhD
Oncology • New Brunswick, NJAssociate Director for Translational Research, Chief, Section of Molecular Oncology, Omar Boraie Chair in Genomic Science
Dr. Ganesan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St
New Brunswick, NJ 08901Phone+1 732-235-6777Fax+1 732-235-7355
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 1999- Brigham and Women's HospitalResidency, Internal Medicine, 1993 - 1996
Yale School of MedicineClass of 1993
Certifications & Licensure
NJ State Medical License 2005 - 2025
MA State Medical License 1996 - 2005- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer Start of enrollment: 2024 Apr 15
Roles: Contact
Publications & Presentations
PubMed
- Evolution of Rapid Clonal Dynamics and Non-Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon Cancer.Srilatha Simhadri, Jillian N Carrick, Susan Murphy, Om A Kothari, Husam Al-Hraishami
JCO Precision Oncology. 2024-12-01 - Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling.Rachel E Yan, Alba Corman, Lyla Katgara, Xiao Wang, Xinhe Xue
Nature Biotechnology. 2024-11-21 - 2 citationsPromoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community-engaged development and pilot testing of...Jinghua An, Jeanne M Ferrante, Myneka Macenat, Shridar Ganesan, Shawna V Hudson
Cancer. 2024-10-15
Journal Articles
- RET Rearrangements Are Actionable Alterations in Breast CancerShridar Ganesan, Siraj M Ali, Kim M Hirshfield, Nature
- PALB2 Connects BRCA1 and BRCA2 in the G2/M Checkpoint ResponseShridar Ganesan, MD, Nature
- Endogenous Retrovirus Expression Is Associated with Response to Immune Checkpoint Blockade in Clear Cell Renal Cell CarcinomaBenjamin G. Vincent, Jonathan S. Serody, Gregory Riedlinger, Shridar Ganesan, The Journal of Clinical Investigation
- Join now to see all
Press Mentions
NYU Langone Launches Molecular Oncology Program, Names LeaderOctober 11th, 2024- NYU Langone Perlmutter Cancer Center Appoints Renowned Physician–Scientist to Build & Lead Groundbreaking Molecular Oncology ProgramOctober 10th, 2024
- Unraveling of Genetic Mechanism Behind Tumor Formation May Improve Targeted Treatment for Cancer PatientsAugust 10th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
